Hims & Hers Health (NYSE:HIMS) is set to report its earnings on Monday, Feb 24 after market close. HIMS stock plunged over 25 ...
Healthcare stock Hims and Hers (HIMS) is sharply lower today but has contrarian potential next week ahead of earnings ...
Telehealth pioneer Hims & Hers Health (HIMS) stock is soaring, with a 12% gain in recent days and a whopping 176% in the last ...
We believe there is minimal cause for concern with HIMS stock, which makes it attractive but highly sensitive to adverse events as its current valuation is extremely ...
Bank of America raised its price target on Hims & Hers stock today, but still thinks it costs twice what it should. At 77 times predicted 2027 earnings, Hims & Hers stock looks too expensive to ...
1d
Axios Vitals on MSNOzempic and Wegovy shortage ends, setting up weight loss drug showdownOzempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply, the FDA declared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results